Head and Neck Carcinoma
80
21
35
32
Key Insights
Highlights
Success Rate
86% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 62/100
6.3%
5 terminated out of 80 trials
86.5%
-0.1% vs benchmark
4%
3 trials in Phase 3/4
31%
10 of 32 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 32 completed trials
Clinical Trials (80)
Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)
The Cancer Connected Access and Remote Expertise Beyond Walls Program to Provide In-Home Cancer Treatment and Improve Treatment Satisfaction in Cancer Patients Living in the Florida Panhandle and Surrounding Areas
Manual Therapy in Treating Fibrosis-Related Late Effect Dysphagia in Head and Neck Cancer Survivors
A New Way to Share Radiation Therapy Plans Between Doctors, CORRECT Trial
Intensity Modulated Proton or X-Ray Therapy After Surgery for Treatment of Head and Neck Cancer, the HEADLIGHT Study
Determining the Biodistribution of an Imaging Tracer (68Ga-FAPi-46) in Patients With Solid Tumors or Hematologic Cancers
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
High Dose Steroid Therapy (Prednisone or Methylprednisolone) for the Improvement of Symptoms of Late Radiation-Associated Lower Cranial Neuropathy in Oropharyngeal Cancer Survivors
Data Collection for the Assessment of Acute and Late Normal Tissue in Patients Treated With Proton Therapy
A Financial Intervention (Financial Compass) to Identify and Address Financial Hardship Among Head and Neck Cancer Patients, Financial Compass Trial
Repeatability and Reproducibility of the ADC Map in Head and Neck Cancer. Prospective Multicenter Study
Antibiotic Treatment Effects on Intratumoral Bacteria Modulation in Surgical Patients With Oral Cancer
Post-Radiation Oral Health in Underserved Head and Neck Cancer Patients
Interdisciplinary Interventions to Address Pain Management Among Head and Neck Cancer Patients
An Integrative Multi-Omic Characterization of Head and Neck Carcinogenesis, Progression and Recurrence
Oropharynx (OPX) Biomarker Trial
Medical Data Collection of Patients With Head and Neck Cancer Treated With Proton Therapy
Bioelectrical Impedance Analysis in Estimating Body Composition in Patients With Stage I-IV Head and Neck Cancer Undergoing Radiation Therapy
Neurofeedback in Decreasing Acute Radiotherapy-Induced Pain in Patients With Head and Neck Cancer
Customized 3D Printed Oral Stents During Head and Neck Radiotherapy